Progress in dorsal root ganglion neurosteroidogenic activity: Basic evidence and pathophysiological correlation

Progress in Neurobiology

Volumn 92, Issue 1, 2010, Pages 33-41

  Schaeffer, Véronique ^a   Meyer, Laurence ^a   Patte Mensah, Christine ^a   Mensah Nyagan, Ayikoe Guy ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Dorsal root ganglion; Neuroactive steroid; Neuron glia crosstalk; Neuroprotection; Neurosteroid; Pain; Sensory system

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; NEUROSTEROID; SUBSTANCE P;

CENTRAL NERVOUS SYSTEM; GLIA CELL; NERVE CONDUCTION; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; SPINAL GANGLION; STEROIDOGENESIS;

EID: 77953922055     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.04.009     Document Type: Review

References (108)

1. Agis-Balboa R.C., Pinna G., Pibiri F., Kadriu B., Costa E., Guidotti A. Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18736-18741.
2. Aldskogius H., Elfvin L.G., Forsman C.A. Primary sensory afferents in the inferior mesenteric ganglion and related nerves of the guinea pig. An experimental study with anterogradely transported wheat germ agglutinin-horseradish peroxidase conjugate. J. Auton. Nerv. Syst. 1986, 15:179-190.
3. Alvarez M.P., Solas M.T., Suarez I., Fernandez B. Glial fibrillary acidic protein-like immunoreactivity in cat satellite cells of sympathetic ganglia. Acta Anat. (Basel) 1989, 136:9-11.
4. Andersson S., Russell D.W. Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:3640-3644.
5. Andersson S., Berman D.M., Jenkins E.P., Russell D.W. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 1991, 354:159-161.
6. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., Garcia-Segura L.M. Brain aromatase is neuroprotective. J. Neurobiol. 2001, 47:318-329.
7. Battaglia G., Rustioni A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J. Comp. Neurol. 1988, 277:302-312.
8. Baulieu, E.E., Robel, P., Schumacher, M., 1999. Contemporary Endocrinology. Totowa, NJ.
9. Belelli D., Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 2005, 6:565-575.
10. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
11. Berman D.M., Russell D.W. Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9359-9363.
12. Chaban V.V., Mayer E.A., Ennes H.S., Micevych P.E. Estradiol inhibits ATP-induced intracellular calcium concentration increase in dorsal root ganglia neurons. Neuroscience 2003, 118:941-948.
13. Chung B.C., Picado-Leonard J., Haniu M., Bienkowski M., Hall P.F., Shively J.E., Miller W.L. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:407-411.
14. Compagnone N.A., Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 2000, 21:1-56.
15. De Biasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:7820-7824.
16. De Nicola A.F., Labombarda F., Deniselle M.C., Gonzalez S.L., Garay L., Meyer M., Gargiulo G., Guennoun R., Schumacher M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol. 2009, 30:173-187.
17. Dunn P.M., Zhong Y., Burnstock G. P2X receptors in peripheral neurons. Prog. Neurobiol. 2001, 65:107-134.
18. Fester L., Ribeiro-Gouveia V., Prange-Kiel J., von Schassen C., Bottner M., Jarry H., Rune G.M. Proliferation and apoptosis of hippocampal granule cells require local oestrogen synthesis. J. Neurochem. 2006, 97:1136-1144.
19. Frank C., Sagratella S. Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog. Neuropsychopharmacol. Biol. Psychiatry 2000, 24:1117-1126.
20. Frye C.A., Rhodes M.E., Rosellini R., Svare B. The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites. Pharmacol. Biochem. Behav. 2002, 74:119-127.
21. Frye C.A., Edinger K.L., Seliga A.M., Wawrzycki J.M. 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology 2004, 29:1019-1027.
22. Garcia-Segura L.M., Naftolin F., Hutchison J.B., Azcoitia I., Chowen J.A. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J. Neurobiol. 1999, 40:574-584.
23. Garcia-Segura L.M., Wozniak A., Azcoitia I., Rodriguez J.R., Hutchison R.E., Hutchison J.B. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 1999, 89:567-578.
24. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
25. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., Azcoitia I. Aromatase: a neuroprotective enzyme. Prog. Neurobiol. 2003, 71:31-41.
26. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., Baulieu E.E., Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 2003, 86:848-859.
27. Giatti S., D'Intino G., Maschi O., Pesaresi M., Garcia-Segura L.M., Calza L., Caruso D., Melcangi R.C. Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem. Int. 2010, 56:118-127.
28. Girard C., Liu S., Cadepond F., Adams D., Lacroix C., Verleye M., Gillardin J.M., Baulieu E.E., Schumacher M., Schweizer-Groyer G. Etifoxine improves peripheral nerve regeneration and functional recovery. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20505-20510.
29. Guennoun R., Schumacher M., Robert F., Delespierre B., Gouezou M., Eychenne B., Akwa Y., Robel P., Baulieu E.E. Neurosteroids: expression of functional 3beta-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells. Eur. J. Neurosci. 1997, 9:2236-2247.
30. Guth L., Zhang Z., Roberts E. Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12308-12312.
31. Haines D.E., Mihailoff G.A., Yezierski R.P. The spinal cord. Fundamental Neuroscience 1997, 129-141. Livingstone Inc., New York. D.E. Haines (Ed.).
32. Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res. Brain Res. Rev. 2005, 48:457-476.
33. Herd M.B., Belelli D., Lambert J.J. Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors. Pharmacol. Ther. 2007, 116:20-34.
34. Higashi T., Nagahama A., Otomi N., Shimada K. Studies on neurosteroids XIX Development and validation of liquid chromatography-tandem mass spectrometric method for determination of 5alpha-reduced pregnane-type neurosteroids in rat brain and serum. J. Chromatogr. B 2007, 848:188-199.
35. Hill M., Cibula D., Havlíkova H., Kancheva L., Fait T., Kancheva R., Parizek A., Starka L. Circulating levels of pregnanolone isomers during the third trimester of human pregnancy. J. Steroid Biochem. Mol. Biol. 2007, 105:166-175.
36. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., Chopde C.T. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology (Berl) 2005, 180:267-278.
37. Ikushiro S., Kominami S., Takemori S. Adrenal P-450scc modulates activity of P-45011 beta in liposomal and mitochondrial membranes. Implication of P-450scc in zone specificity of aldosterone biosynthesis in bovine adrenal. J. Biol. Chem. 1992, 267:1464-1469.
38. Jevtovic-Todorovic V., Covey D.F., Todorovic S.M. Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain?. Psychoneuroendocrinology 2009, 34(Suppl. 1):S178-S185.
39. Kibaly C., Patte-Mensah C., Mensah-Nyagan A.G. Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J. Neurochem. 2005, 93:1220-1230.
40. Kibaly C., Meyer L., Patte-Mensah C., Mensah-Nyagan A.G. Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord. FASEB J. 2008, 22:93-104.
41. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:1852-1857.
42. Koenig H.L., Schumacher M., Ferzaz B., Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
43. Lauber M.E., Lichtensteiger W. Ontogeny of 5 alpha-reductase (type 1) messenger ribonucleic acid expression in rat brain: early presence in germinal zones. Endocrinology 1996, 137:2718-2730.
44. Le Goascogne C., Robel P., Gouezou M., Sananes N., Baulieu E.E., Waterman M. Neurosteroids: cytochrome P-450scc in rat brain. Science 1987, 237:1212-1215.
45. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007, 144:1293-1304.
46. Martini L., Magnaghi V., Melcangi R.C. Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system. Steroids 2003, 68:825-829.
47. Matteson K.J., Chung B.C., Urdea M.S., Miller W.L. Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes. Endocrinology 1986, 118:1296-1305.
48. Matthews M.R., Cuello A.C. Substance P-immunoreactive peripheral branches of sensory neurons innervate guinea pig sympathetic neurons. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:1668-1672.
49. McCullough L.D., Blizzard K., Simpson E.R., Oz O.K., Hurn P.D. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J. Neurosci. 2003, 23:8701-8705.
50. Melcangi R.C., Celotti F., Martini L. Progesterone 5-alpha-reduction in neuronal and in different types of glial cell cultures: type 1 and 2 astrocytes and oligodendrocytes. Brain Res. 1994, 14:202-206.
51. Melcangi R.C., Poletti A., Cavarretta I., Celotti F., Colciago A., Magnaghi V., Motta M., Negri-Cesi P., Martini L. The 5alpha-reductase in the central nervous system: expression and modes of control. J. Steroid Biochem. Mol. Biol. 1998, 65:295-299.
52. Melcangi R.C., Ballabio M., Cavarretta I., Gonzalez L.C., Leonelli E., Veiga S., Martini L., Magnaghi V. Effects of neuroactive steroids on myelin of peripheral nervous system. J. Steroid Biochem. Mol. Biol. 2003, 85:323-327.
53. Melcangi R.C., Garcia-Segura L.M., Mensah-Nyagan A.G. Neuroactive steroids: state of the art and new perspectives. Cell. Mol. Life Sci. 2008, 65:777-797.
54. Mellon S.H., Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 2002, 13:35-43.
55. Mensah-Nyagan A.G., Feuilloley M., Dupont E., Do-Rego J.L., Leboulenger F., Pelletier G., Vaudry H. Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci. 1994, 14:7306-7318.
56. Mensah-Nyagan A.G., Do-Rego J.L., Feuilloley M., Marcual A., Lange C., Pelletier G., Vaudry H. In vivo and in vitro evidence for the biosynthesis of testosterone in the telencephalon of the female frog. J. Neurochem. 1996, 67:413-422.
57. Mensah-Nyagan A.G., Feuilloley M., Do-Rego J.L., Marcual A., Lange C., Tonon M.C., Pelletier G., Vaudry H. Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1423-1428.
58. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 1999, 51:63-81.
59. Mensah-Nyagan A.G., Beaujean D., Luu-The V., Pelletier G., Vaudry H. Anatomical and biochemical evidence for the synthesis of unconjugated and sulfated neurosteroids in amphibians. Brain Res. Brain Res. Rev. 2001, 37:13-24.
60. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., Vaudry H. Regulation of neurosteroid biosynthesis in the frog diencephalon by GABA and endozepines. Horm. Behav. 2001, 40:218-225.
61. Mensah-Nyagan A.G., Saredi S., Schaeffer V., Kibaly C., Meyer L., Melcangi R.C., Patte-Mensah C. Assessment of neuroactive steroid formation in diabetic rat spinal cord using high-performance liquid chromatography and continuous flow scintillation detection. Neurochem. Int. 2008, 52:554-559.
62. Mensah-Nyagan A.G., Meyer L., Schaeffer V., Kibaly C., Patte-Mensah C. Evidence for a key role of steroids in the modulation of pain. Psychoneuroendocrinology 2009, 34:S169-S177.
63. Meyer L., Venard C., Schaeffer V., Patte-Mensah C., Mensah-Nyagan A.G. The biological activity of 3alpha-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury. Neurobiol. Dis. 2008, 30:30-41.
64. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 1999, 57:1-164.
65. Millan M.J. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
66. Mills C.D., Bitler J.L., Woolf C.J. Role of the peripheral benzodiazepine receptor in sensory neuron regeneration. Mol. Cell. Neurosci. 2005, 30:228-237.
67. Morohashi K., Sogawa K., Omura T., Fujii-Kuriyama Y. Gene structure of human cytochrome P-450(SCC), cholesterol desmolase. J. Biochem. 1987, 101:879-887.
68. Naik A.K., Pathirathna S., Jevtovic-Todorovic V. GABAA receptor modulation in dorsal root ganglia in vivo affects chronic pain after nerve injury. Neuroscience 2008, 154:1539-1553.
69. Nascimento R.S., Santiago M.F., Marques S.A., Allodi S., Martinez A.M. Diversity among satellite glial cells in dorsal root ganglia of the rat. Br. J. Med. Biol. Res. 2008, 41:1007-1011.
70. Nelson D.R., Kamataki T., Waxman D.J., Guengerich F.P., Estabrook R.W., Feyereisen R., Gonzalez F.J., Coon M.J., Gunsalus I.C., Gotoh O., et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell. Biol. 1993, 12:1-51.
71. Normington K., Russell D.W. Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions. J. Biol. Chem. 1992, 267:19548-19554.
72. Ohtori, S., Takahashi, K., Moriya, H., Myers, R.R., 2004. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine (Phila Pa 1976) 29, 1082-1088.
73. Oonk R.B., Parker K.L., Gibson J.L., Richards J.S. Rat cholesterol side-chain cleavage cytochrome P-450 (P-450scc) gene. Structure and regulation by cAMP in vitro. J. Biol. Chem. 1990, 265:22392-22401.
74. Pathirathna S., Brimelow B.C., Jagodic M.M., Krishnan K., Jiang X., Zorumski C.F., Mennerick S., Covey D.F., Todorovic S.M., Jevtovic-Todorovic V. New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5alpha-reduced neuroactive steroids. Pain 2005, 114:429-443.
75. Patte-Mensah C., Kappes V., Freund-Mercier M.J., Tsutsui K., Mensah-Nyagan A.G. Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J. Neurochem. 2003, 86:1233-1246.
76. Patte-Mensah C., Kibaly C., Boudard D., Schaeffer V., Begle A., Saredi S., Meyer L., Mensah-Nyagan A.G. Neurogenic pain and steroid synthesis in the spinal cord. J. Mol. Neurosci. 2006, 28:17-31.
77. Patte-Mensah C., Kibaly C., Mensah-Nyagan A.G. Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9044-9049.
78. Patte-Mensah C., Li S., Mensah-Nyagan A.G. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell. Mol. Life Sci. 2004, 61:2274-2284.
79. Patte-Mensah C., Penning T.M., Mensah-Nyagan A.G. Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord. J. Comp. Neurol. 2004, 477:286-299.
80. Payne A.H., Hales D.B. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 2004, 25:947-970.
81. Pelletier G., Luu-The V., Labrie F. Immunocytochemical localization of type I 17 beta-hydroxysteroid dehydrogenase in the rat brain. Brain Res. 1995, 704:233-239.
82. Pinna G., Dong E., Matsumoto K., Costa E., Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2035-2040.
83. Ribeiro-da-Silva A., Hokfelt T. Neuroanatomical localisation of Substance P in the CNS and sensory neurons. Neuropeptides 2000, 34:256-271.
84. Roby K.F., Larsen D., Deb S., Soares M.J. Generation and characterization of antipeptide antibodies to rat cytochrome P-450 side-chain cleavage enzyme. Mol. Cell. Endocrinol. 1991, 79:13-20.
85. Rupprecht R., Rammes G., Eser D., Baghai T.C., Schule C., Nothdurfter C., Troxler T., Gentsch C., Kalkman H.O., Chaperon F., Uzunov V., McAllister K.H., Bertaina-Anglade V., La Rochelle C.D., Tuerck D., Floesser A., Kiese B., Schumacher M., Landgraf R., Holsboer F., Kucher K. Translocator protein (18kD) as target for anxiolytics without benzodiazepine-like side effects. Science 2009, 325(5939):490-493.
86. Schaeffer V., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J. Neurobiol. 2006, 66:868-881.
87. Schaeffer V., Meyer L., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells. Neurochem. Int. 2008, 52:948-955.
88. Schaeffer V., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition. Neuroscience 2008, 151:758-770.
89. Schaeffer V., Meyer L., Patte-Mensah C., Eckert A., Mensah-Nyagan A.G. Sciatic nerve injury induces apoptosis of dorsal root ganglion satellite glial cells and selectively modifies neurosteroidogenesis in sensory neurons. Glia 2009, 58:169-180.
90. Schumacher M., Guennoun R., Mercier G., Desarnaud F., Lacor P., Benavides J., Ferzaz B., Robert F., Baulieu E.E. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Brain Res. Rev. 2001, 37:343-359.
91. Schumacher M., Guennoun R., Ghoumari A., Massaad C., Robert F., El-Etr M., Akwa Y., Rajkowski K., Baulieu E.E. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr. Rev. 2007, 28:387-439.
92. Stephenson J.L., Byers M.R. GFAP immunoreactivity in trigeminal ganglion satellite cells after tooth injury in rats. Exp. Neurol. 1995, 131:11-22.
93. Suhara K., Gomi T., Sato H., Itagaki E., Takemori S., Katagiri M. Purification and immunochemical characterization of the two adrenal cortex mitochondrial cytochrome P-450-proteins. Arch. Biochem. Biophys. 1978, 190:290-299.
94. Szekely J.I., Torok K., Mate G. The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites. Curr. Pharm. Des. 2002, 8:887-912.
95. Tsutsui K., Yamazaki T. Avian neurosteroids. I. Pregnenolone biosynthesis in the quail brain. Brain Res. 1995, 678:1-9.
96. Ugale R.R., Sharma A.N., Kokare D.M., Hirani K., Subhedar N.K., Chopde C.T. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats. Brain Res. 2007, 1184:193-201.
97. Ukena K., Usui M., Kohchi C., Tsutsui K. Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neonatal change in rats. Endocrinology 1998, 139:137-147.
98. Usui M., Yamazaki T., Kominami S., Tsutsui K. Avian neurosteroids. II. Localization of a cytochrome P450scc-like substance in the quail brain. Brain Res. 1995, 678:10-20.
99. Veiga S., Azcoitia I., Garcia-Segura L.M. Extragonadal synthesis of estradiol is protective against kainic acid excitotoxic damage to the hippocampus. Neuroreport 2005, 16:1599-1603.
100. Venard C., Boujedaini N., Belon P., Mensah-Nyagan A.G., Patte-Mensah C. Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience 2008, 153:154-161.
101. Venard C., Boujedaini N., Mensah-Nyagan A.G., Patte-Mensah C. Comparative analysis of gelsemine and gelsemium sempervirens activity on neurosteroid allopregnanolone formation in the spinal cord and limbic system. Evid. Based Complement Alternat. Med. 2009, 10.1093/ecam/nep083.
102. Verleye M., Akwa Y., Liere P., Ladurelle N., Pianos A., Eychenne B., Schumacher M., Gillardin J.M. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol. Biochem. Behav. 2005, 82:712-720.
103. Viéro C., Mechaly I., Aptel H., Puech S., Valmier J., Bancel F., Dayanithi G. Rapid inhibition of Ca2+ influx by neurosteroids in murine embryonic sensory neurones. Cell Calcium 2006, 40:383-391.
104. Wall P.D., Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 1983, 17:321-339.
105. Wilson J.D., Griffin J.E., Russell D.W. Steroid 5 alpha-reductase 2 deficiency. Endocr. Rev. 1993, 14:577-593.
106. Woodham P., Anderson P.N., Nadim W., Turmaine M. Satellite cells surrounding axotomised rat dorsal root ganglion cells increase expression of a GFAP-like protein. Neurosci. Lett. 1989, 98:8-12.
107. Yokoi H., Tsuruo Y., Ishimura K. Steroid 5alpha-reductase type 1 immunolocalized in the rat peripheral nervous system and paraganglia. Histochem. J. 1998, 30:731-739.
108. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 2001, 429:23-37.